Webinar Services for Pharma, Biotech and Medtech that Reach and Engage the Right Audience

Explore our pharma webinar services, featuring upcoming and on-demand webinars designed to reach and engage the right audience across Pharma, Biotech and MedTech.

42%

Average Engagement Rate

Our pharma webinar services drives meaningful interaction beyond just registrations.

Not just registrations. Measurable engagement.

9th July 2026

09/07/2026

Characterize Your Biologics with Smart and Science-driven Concepts

How to choose the best panel of phase-appropriate analytical methods for complex modalities while maintaining aggressive development timelines

Coriolis

25th June 2026

25/06/2026

Simplifying ADC Development: An Integrated Path from Concept to Commercialization

Best practices for scalable ADC manufacturing, end to end integration and reducing complexity across the full ADC development lifecycle.

Lonza

5th March 2026

05/03/2026

Formulating the Future:
Nucleic Acid Therapeutics Explained

Critical quality attributes for mRNA-LNP formulations, LNP delivery system stability and the analytical toolbox for nucleic acid therapeutics.

Coriolis

25th March 2026

25/03/2026

Scaling Up Oral Solid Dose Manufacturing for Late-Phase Success

How to select the right CDMO, translate lab data into scalable OSD processes and apply QbD principles to avoid delays in late-phase manufacturing.

Upperton

18th November 2025

18/11/2025

Subvisible Particle Analysis: Ensuring Quality from Lab Bench to GMP

Regulatory requirements, method validation and variability control for subvisible particle analysis from R&D through to GMP compliance.

Coriolis

13th November 2025

13/11/2025

Unlocking Therapeutic Potential Through Nasal Drug Repositioning

Evaluating nasal repositioning potential, covering clinical suitability, regulatory strategy, delivery system selection and commercial impact.

Aptar

1st October 2025

01/10/2025

Nose-to-Brain Drug Delivery and Device Selection

Key delivery targets, transport mechanisms and device considerations for nose to brain CNS delivery, from formulation to regulatory submission.

Upperton

16th September 2025

16/09/2025

Managing the uncertainty in treatment exposure to increase success in clinical trials

Digital adherence monitoring, RBQM integration and the estimand framework to reduce trial variability and strengthen exposure response analysis.

Aardex

10th September 2025

10/09/2025

Could Transmucosal Delivery Be the Right Route for Your API?

API requirements for transmucosal delivery, Mucofilm compatibility and key development steps from feasibility through to commercial manufacture.

Adhex

18th September 2025

18/09/2025

Holistic approach to Intravitreal Injection combining Packaging and Device

The full value chain for intravitreal injection, from primary packaging and coating technology to filtered needle selection and USP 789 particle compliance.

banner, Terumo

1st July 2025

01/07/2025

Smarter Drug Development for Biologics with In Silico Modelling

Computational approaches to biologics developability, formulation optimisation and stability prediction, with case studies on risk reduction.

Coriolis

9th July 2025

09/07/2025

Targeting the Airways: Innovations in Soft Mist Drug Delivery for All Ages – Including Infants

Soft mist aerosol technology for targeted respiratory deposition across all age groups, including a pacifier-based delivery interface designed for infants.

banner, Ursatec

25th June 2025

25/06/2025

Navigating the sterile fill finish CDMO landscape for development and manufacturing success

CDMO capability assessment, facility design, EU GMP Annex 1 compliance and formulation strategies for sterile liquid and powder drug products.

Upperton

29th May 2025

29/05/2025

Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs

Preclinical intranasal and inhalation protocols, covering system selection, animal model design, insufflator and micro sprayer technologies.

Aptar

5th June 2025

05/06/2025

Unlocking the Future of Drug Development: How PBBM & Solid Form Screening Drive Early-Phase Success

Solid form screening, PBBM modelling and in vitro testing to identify absorption risks, guide form selection and accelerate early phase development.

Lonza

8th April 2025

08/04/2025

EU GMP Annex 1: New Standards for Injectable Drug Manufacturing

Revised EMA GMP Annex 1 guidelines, impact on contamination control strategy and the role of primary packaging suppliers in sterility assurance.

Aptar

29th November, 2023

29/11/2023

Every particle matters

Particle identification and characterisation tools for biologics and cell and gene therapy, covering origins, analytical methods and troubleshooting.

Coriolis

21st February, 2024

21/02/2024

Road To Success: Mapping drug development from preclinical to commercialization

A phase appropriate development roadmap for biologics, covering formulation, analytical characterisation and derisking from preclinical to market.

Coriolis

7th March 2024

07/03/2024

Packaging Precision: Insights on Ensuring Stability and Shelf-Life

Capsule and packaging material selection for OSD formulations, strategies for overcoming stability challenges and cost optimisation during scale up.

8th May 2024

08/05/2024

Master the Next Generation of Clinical Research: 5 Strategies to Dramatically Improve Data Quality

Five strategies for clinical data quality, covering data management, risk based quality management, AI assisted review and proactive error detection.

Medidata

7th May 2024

07/05/2024

Shedding light on surfactants used as excipient for biologics

Polysorbate degradation mechanisms, surfactant characterisation strategies and multidimensional chromatography for surfactant analysis in biologics.

Coriolis

10th April 2025

10/04/2025

Advancements in On-Body Drug Delivery Systems: Overcoming Challenges and Driving Innovation

Advances in on-body delivery for high volume and viscous drugs, with strategies for optimising platforms from prototype through to clinical readiness.

27th June, 2024

27/06/2024

Preservative-Free Spray Applications and Their Compliant Road to Market

Preservative-free spray system options, drug device combination under EU MDR and regulatory documentation requirements for market entry.

Ursatec

11th July, 2024

11/07/2024

Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications

Selecting the right pre-filled syringe for biologics and ophthalmic applications, covering plasma coating, viscosity, compatibility and analytics.

Stevanato

10th July, 2024

10/07/2024

Lyo-Modelling Reduce risks on the road to commercialization through process understanding

Lyophilisation modelling for primary drying optimisation, robustness analysis and in silico assessment of process failures to ensure product quality.

Coriolis

1st October, 2024

01/10/2024

Sharpening the Future: New Opportunities for Implant Injection

Drug implant technology advances, applicator design, manufacturing quality standards and market opportunities for long acting implant systems.

Gaplast

20th November, 2024

20/11/2024

Paving the way to a successful AAV product

Analytical methods for AAV characterisation, quality attributes for manufacturing and orthogonal approaches for infectivity and capsid ratios.

Coriolis

22nd October, 2024

22/10/2024

Unlocking Success in Inhaled & Nasal Drug Clinical Studies

Critical factors in OINDP clinical development, CMC risk mitigation and how to balance preparation levels to meet regulatory expectations.

Nanopharm

14th November 2024

14/11/2024

How RTU Solutions Can Meet GMP Annex 1 Requirements

Pre-sterilised ready to use containers as a compliant aseptic solution, reducing contamination risk and simplifying EU GMP Annex 1 compliance.

Stevanato

27th February 2025

27/02/2025

Developability Assessment and Early Formulation Studies for Biologics

Candidate selection, biophysical characterisation and pre-formulation screening to reduce late stage failures and build a strong data foundation.

Coriolis

26th February 2025

26/02/2025

Transitioning an Oral Solid Dosage from Phase 1 to Phase 2 studies: Formulation challenges and strategies

Development timelines, formulation optimisation strategies and CDMO selection for transitioning oral solid dosage forms from Phase 1 to Phase 2.

Upperton

Webinar services for Pharma, Biotech and MedTech organisations, delivered end-to-end

from promotion and targeting through to delivery and follow up.

Explore Our Services

Turn Registrants Into Relationships

Most registrants disappear after the session ends. We help you
open the right doors before, during, and after the webinar.